Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein

Tomić, Draško (2021) Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Dataset] (Unpublished)

	Archive (TGZ) (Efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein) - Accepted Version - research data Available under License Creative Commons Public Domain Dedication. Download (1GB)
	Microsoft Word (The description of the data deposited) - Accepted Version - research data Download (720B)

Abstract

These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein was analyzed. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated.

Item Type:	Dataset
Uncontrolled Keywords:	SARS-CoV-2; spike glycoprotein; FDA approved antiviral drugs; HIV drugs
Subjects:	BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences > Human Genetics, Genomics and Proteomics BIOMEDICINE AND HEALTHCARE > Pharmacy > Medical Biochemistry BIOTECHNICAL SCIENCES > Biotechnology > Bioinformatics
Divisions:	Center for Informatics and Computing
Projects:	Project title Project leader Project code Project type DATACROSS - Napredne metode i tehnologije u znanosti o podatcima i kooperativnim sustavima-DATACROSS Sven Lončarić; Petrović Ivan KK.01.1.1.01.009 EK
Depositing User:	Draško Tomić
Date Deposited:	18 Jan 2021 07:30
URI:	http://fulir.irb.hr/id/eprint/6161

Available Versions of this Item

• VINI in silico model of cancer (deposited 03 Apr 2020 06:22)
  • Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein (deposited 18 Jan 2021 07:30) [Currently Displayed]

Actions (login required)

View Item